161 related articles for article (PubMed ID: 29916101)
21. Norcantharidin blocks Wnt/β-catenin signaling via promoter demethylation of WIF-1 in glioma.
Xie D; Xie J; Wan Y; Ma L; Qi X; Wang K; Yang S
Oncol Rep; 2016 Apr; 35(4):2191-7. PubMed ID: 26781164
[TBL] [Abstract][Full Text] [Related]
22. MiR-27a regulates Wnt/beta-catenin signaling through targeting SFRP1 in glioma.
Wang K; Xie D; Xie J; Wan Y; Ma L; Qi X; Yang S
Neuroreport; 2015 Aug; 26(12):695-702. PubMed ID: 26164457
[TBL] [Abstract][Full Text] [Related]
23. RUNX3 is down-regulated in glioma by Myc-regulated miR-4295.
Li X; Zheng J; Diao H; Liu Y
J Cell Mol Med; 2016 Mar; 20(3):518-25. PubMed ID: 26756701
[TBL] [Abstract][Full Text] [Related]
24. PAX3 Promotes Proliferation of Human Glioma Cells by WNT/β-Catenin Signaling Pathways.
Liang X; Dong Z; Bin W; Dekang N; Xuhang Z; Shuyuan Z; Liwen L; Kai J; Caixing S
J Mol Neurosci; 2019 May; 68(1):66-77. PubMed ID: 30826985
[TBL] [Abstract][Full Text] [Related]
25. RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR-148a-3p/DNMT1 axis.
Jili S; Eryong L; Lijuan L; Chao Z
Cell Biochem Funct; 2016 Dec; 34(8):597-605. PubMed ID: 27859417
[TBL] [Abstract][Full Text] [Related]
26. RUNX3-mediated transcriptional inhibition of Akt suppresses tumorigenesis of human gastric cancer cells.
Lin FC; Liu YP; Lai CH; Shan YS; Cheng HC; Hsu PI; Lee CH; Lee YC; Wang HY; Wang CH; Cheng JQ; Hsiao M; Lu PJ
Oncogene; 2012 Sep; 31(39):4302-16. PubMed ID: 22231444
[TBL] [Abstract][Full Text] [Related]
27. Glucocorticoid receptor β regulates injury-mediated astrocyte activation and contributes to glioma pathogenesis via modulation of β-catenin/TCF transcriptional activity.
Yin Y; Zhang X; Li Z; Deng L; Jiao G; Zhang B; Xie P; Mu H; Qiao W; Zou J
Neurobiol Dis; 2013 Nov; 59():165-76. PubMed ID: 23906498
[TBL] [Abstract][Full Text] [Related]
28. Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells.
Zhang X; Zheng K; Li C; Zhao Y; Li H; Liu X; Long Y; Yao J
Oncol Rep; 2017 May; 37(5):2847-2856. PubMed ID: 28339056
[TBL] [Abstract][Full Text] [Related]
29. RUNX3 plays a tumor suppressor role by inhibiting cell migration, invasion and angiogenesis in oral squamous cell carcinoma.
Zhou WN; Du YF; Bai J; Song XM; Zheng Y; Yuan H; Zhang W; Zhang ZD; Wu YN
Oncol Rep; 2017 Oct; 38(4):2378-2386. PubMed ID: 28765934
[TBL] [Abstract][Full Text] [Related]
30. CACNA2D3 is downregulated in gliomas and functions as a tumor suppressor.
Jin Y; Cui D; Ren J; Wang K; Zeng T; Gao L
Mol Carcinog; 2017 Mar; 56(3):945-959. PubMed ID: 27583705
[TBL] [Abstract][Full Text] [Related]
31. Inactivation of PI3K/AKT signaling inhibits glioma cell growth through modulation of β-catenin-mediated transcription.
Han L; Yang Y; Yue X; Huang K; Liu X; Pu P; Jiang H; Yan W; Jiang T; Kang C
Brain Res; 2010 Dec; 1366():9-17. PubMed ID: 20888802
[TBL] [Abstract][Full Text] [Related]
32. R132H mutation in IDH1 gene reduces proliferation, cell survival and invasion of human glioma by downregulating Wnt/β-catenin signaling.
Cui D; Ren J; Shi J; Feng L; Wang K; Zeng T; Jin Y; Gao L
Int J Biochem Cell Biol; 2016 Apr; 73():72-81. PubMed ID: 26860959
[TBL] [Abstract][Full Text] [Related]
33. Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of glioma cells by inactivating Wnt/β-catenin signaling.
Tao Q; Wu C; Xu R; Niu L; Qin J; Liu N; Zhang P; Wang C
Cell Tissue Res; 2017 Dec; 370(3):379-390. PubMed ID: 28815294
[TBL] [Abstract][Full Text] [Related]
34. Tumor suppressor, AT motif binding factor 1 (ATBF1), translocates to the nucleus with runt domain transcription factor 3 (RUNX3) in response to TGF-beta signal transduction.
Mabuchi M; Kataoka H; Miura Y; Kim TS; Kawaguchi M; Ebi M; Tanaka M; Mori Y; Kubota E; Mizushima T; Shimura T; Mizoshita T; Tanida S; Kamiya T; Asai K; Joh T
Biochem Biophys Res Commun; 2010 Jul; 398(2):321-5. PubMed ID: 20599712
[TBL] [Abstract][Full Text] [Related]
35. EZH2 promotes cell proliferation by regulating the expression of RUNX3 in laryngeal carcinoma.
Lian R; Ma H; Wu Z; Zhang G; Jiao L; Miao W; Jin Q; Li R; Chen P; Shi H; Yu W
Mol Cell Biochem; 2018 Feb; 439(1-2):35-43. PubMed ID: 28795320
[TBL] [Abstract][Full Text] [Related]
36. Role of RUNX3 in suppressing metastasis and angiogenesis of human prostate cancer.
Chen F; Wang M; Bai J; Liu Q; Xi Y; Li W; Zheng J
PLoS One; 2014; 9(1):e86917. PubMed ID: 24475196
[TBL] [Abstract][Full Text] [Related]
37. ICAT inhibits glioblastoma cell proliferation by suppressing Wnt/β-catenin activity.
Zhang K; Zhu S; Liu Y; Dong X; Shi Z; Zhang A; Liu C; Chen L; Wei J; Pu P; Zhang J; Jiang T; Han L; Kang C
Cancer Lett; 2015 Feb; 357(1):404-411. PubMed ID: 25434796
[TBL] [Abstract][Full Text] [Related]
38. Restored expression of the tumor suppressor gene RUNX3 reduces cancer stem cells in hepatocellular carcinoma by suppressing Jagged1-Notch signaling.
Nishina S; Shiraha H; Nakanishi Y; Tanaka S; Matsubara M; Takaoka N; Uemura M; Horiguchi S; Kataoka J; Iwamuro M; Yagi T; Yamamoto K
Oncol Rep; 2011 Sep; 26(3):523-31. PubMed ID: 21637926
[TBL] [Abstract][Full Text] [Related]
39. β-catenin/Tcf-4 complex transcriptionally regulates AKT1 in glioma.
Chen L; Huang K; Han L; Shi Z; Zhang K; Pu P; Jiang C; Kang C
Int J Oncol; 2011 Oct; 39(4):883-90. PubMed ID: 21720709
[TBL] [Abstract][Full Text] [Related]
40. Loss of FOXN3 in colon cancer activates beta-catenin/TCF signaling and promotes the growth and migration of cancer cells.
Dai Y; Wang M; Wu H; Xiao M; Liu H; Zhang D
Oncotarget; 2017 Feb; 8(6):9783-9793. PubMed ID: 28039460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
